Munich, Germany

Heinrich Gottlinger

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Heinrich Gottlinger. Retrieved from https://idiyas.com/inventor/heinrich-gottlinger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 52(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Heinrich Gottlinger: Innovator in HIV Research

Introduction

Heinrich Gottlinger is a prominent inventor based in Munich, Germany. He has made significant contributions to the field of HIV research, particularly in the development of innovative vectors for gene transfer and vaccine development. His work has the potential to impact the future of HIV treatment and prevention.

Latest Patents

Heinrich Gottlinger holds a patent for "Vectors containing HIV packaging sequences, packaging defective HIV." This patent describes packaging defective and packaging proficient HIV vectors that can be utilized to establish HIV packaging defective cell lines. These cell lines are instrumental in developing vaccines, HIV antibodies, and systems for gene transfer. The packaging proficient vector is specifically designed to target HIV target cells, showcasing its potential in therapeutic applications.

Career Highlights

Gottlinger is associated with the Dana-Farber Cancer Institute Inc., where he continues to advance his research in HIV. His work is characterized by a commitment to understanding and combating the challenges posed by HIV, making him a key figure in the field.

Collaborations

Heinrich Gottlinger has collaborated with notable scientists such as Joseph G. Sodroski and William A. Haseltine. These collaborations have further enriched his research and contributed to the collective knowledge in HIV studies.

Conclusion

Heinrich Gottlinger is a vital contributor to HIV research, with a focus on innovative solutions for gene transfer and vaccine development. His patent and collaborations highlight his dedication to advancing the understanding and treatment of HIV.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…